Neurogenic Bladder CME:

Background: Upper urinary tract urothelial tumors involving the renal pelvis or ureter account for 5% to 7% of all renal tumors and about 5% of all urothelial tumors. Renal pelvic tumors are not ...

Bladder Cancer General Considerations This is the second most common urologic malignancy. Ninety percent of the cases are transitional cell carcinoma. Sixty to 75% of lesions are superficial ...

BERKELEY, CA (UroToday.com) - In this in vitro study, we demonstrated that growth inhibitory activity of interferon-α2b (IFN-α2b) on bladder cancer T24 cells was synergistically enhanced with maitake mushroom ...

BERKELEY, CA (UroToday.com) -   "Every patient carries her or his own doctor inside." Albert Schweitzer (1875-1965)

BERKELEY, CA (UroToday.com) - Radiotherapy, given in 20-25 fractions over 4-5 weeks, is usually the second choice for the treatment of muscle-invasive bladder cancer, behind radical cystectomy.

BERKELEY, CA (UroToday.com) - Lymph node density (LND) has been used as a prognostic factor for other solid tumors, including esophageal and bladder cancer, but had never been described in penile cancer. ...

BERKELEY, CA (UroToday.com) - Currently several urine-based tumour markers are available for the detection of bladder cancer recurrence.

BERKELEY, CA (UroToday.com) - This retrospective study sought to identify clinical and urodynamic differences between female overactive bladder (OAB) patients with and without urodynamically proven detrusor ...

BERKELEY, CA (UroToday.com) - The relation between the complication rate and patient gender is controversial, and the literature data are quite ambiguous with a few published studies failing to show any ...

BERKELEY, CA (UroToday.com) - Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976,

BERKELEY, CA (UroToday.com) -

BERKELEY, CA (UroToday.com) - The first placebo-controlled superiority trial between two antimuscarinic agents was recently performed comparing fesoterodine 8mg to tolterodine ER 4mg and placebo.

BERKELEY, CA (UroToday.com) - The treatment of lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction (BOO) makes up a significant amount of the workload of most urologists.

BERKELEY, CA (UroToday.com) -   Fluorescence cystoscopy in bladder cancer: European expert panel recommendations and personal comments    

BERKELEY, CA (UroToday.com) - Whilst the two major risk factors for bladder cancer are smoking and occupational exposure to chemicals, there is also evidence of a genetic component to its aetiology.

BERKELEY, CA (UroToday.com) - Approximately one out of every four patients with T1-4 staged bladder cancer are known to harbour metastatic pelvic lymph-nodes at the time of undergoing radical cystectomy ...

BERKELEY, CA (UroToday.com) - A major dilemma among patients with non-muscle-invasive bladder cancer (NMIBC) and their physicians is the choice of an appropriate course of action following failure of intravesical ...

BERKELEY, CA (UroToday.com) -   A case report and review of the literature    

BERKELEY, CA (UroToday.com) - In this article, we set out to define certain pre-cystectomy criteria that could be predictive of prostate-invasion of urothelial carcinoma to serve as potential selection ...